CCNE1 and ovarian cancer: Finally, we demonstrated that SNS-032 effectively suppressed the tumorigenecity of ovarian cancer cells with elevated CCNE1 expression by prolonging the survival of animals bearing tumors derived from ovarian cancer cells with elevated CCNE1 expression and inhibiting peritoneal metastatic colonization.